Association between Fluid Balance and Treatment Outcome of Ibuprofen for Patent Ductus Arteriosus in Preterm Infants

被引:1
|
作者
Liu, Chang [1 ,2 ,3 ,4 ]
Shi, Yuan [1 ,2 ,3 ,4 ]
机构
[1] Chongqing Med Univ, Childrens Hosp, Dept Neonatol, Chongqing 400014, Peoples R China
[2] Natl Clin Res Ctr Child Hlth & Disorders, Chongqing 400014, Peoples R China
[3] Minist Educ, Key Lab Child Dev & Disorders, Chongqing 400014, Peoples R China
[4] Chongqing Key Lab Pediat, Chongqing 400014, Peoples R China
关键词
patent ductus arteriosus; fluid balance; ibuprofen; preterm infants; BRONCHOPULMONARY DYSPLASIA; GROWTH VELOCITY; RISK-FACTORS; RESTRICTION; CLOSURE; LIFE; PREDICTORS; MANAGEMENT;
D O I
10.31083/j.rcm2403078
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Excessive fluid intake is a predictor of the development of patent ductus arteriosus (PDA) in preterm infants. Previous studies have examined the relationship between fluid intake and outcomes following ibuprofen for PDA. However, there is a lack of data to determine whether fluid balance has an effect on ibuprofen treatment for PDA. Therefore, this study sought to determine the relationship between fluid balance and outcomes following treatment with ibuprofen for PDA. Methods: We conducted a retrospective study of 110 infants admitted to the Children's Hospital of Chongqing Medical University between January 2017 and April 2022, who were treated with ibuprofen for hemodynamically significant PDA (hsPDA). We calculated the average fluid balance before and during the two courses of ibuprofen treatment and whether they were significantly associated with outcomes in hsPDA patients. Results: In the first course of ibuprofen treatment (FIT), responders had lower fluid balance before FIT compared to non-responders [median 31.82 (18.01, 39.66) vs 34.68 (25.31, 43.56) mL/kg/day; p = 0.049], while the fluid balance during FIT [median 40.61 (33.18, 63.06) vs 42.65 (30.02, 57.96) mL/kg/day; p = 0.703] did not differ between responders and non-responders. Fluid balance before the second course of ibuprofen treatment (SIT) (mean 41.58 +/- 14.26 vs 35.74 +/- 10.99 mL/kg/day; p = 0.322) and during SIT (mean 39.21 +/- 12.65 vs 37.00 +/- 21.38 mL/kg/day; p = 0.813) was not found to have a significant association with SIT outcome. Multivariate logistic regression analysis showed fluid balance before FIT was a predictor for FIT success [Odds ratio (OR): 0.967; 95% confidence interval (CI): 0.935-0.999; p = 0.042]. Fluid balance within the first week of life had a greater association with the FIT outcome (OR: 0.967, 95% CI: 0.939-0.996, p = 0.027). Gestational diabetes mellitus and higher Apgar scores decreased the possibility of PDA closure after FIT. Conclusions: Lower fluid balance before FIT, especially within the first week of life appeared to be a predictor for closure of hsPDA after FIT in preterm infants.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Prophylaxis of patent ductus arteriosus with ibuprofen in preterm infants
    Dani, C
    Bertini, G
    Reali, MF
    Murru, P
    Fabris, C
    Vangi, V
    Rubaltelli, FF
    ACTA PAEDIATRICA, 2000, 89 (11) : 1369 - 1374
  • [2] Fluid and electrolyte management in preterm infants with patent ductus arteriosus
    Lalitha, R.
    Surak, A.
    Bitar, E.
    Hyderi, A.
    Kumaran, K.
    JOURNAL OF NEONATAL-PERINATAL MEDICINE, 2022, 15 (04) : 689 - 697
  • [3] Urinary aquaporin-2 excretion during ibuprofen or indomethacin treatment in preterm infants with patent ductus arteriosus
    Li, Yanhong
    Zelenina, Marina
    Plat-Willson, Genevieve
    Marcoux, Marie-Odile
    Aperia, Anita
    Casper, Charlotte
    ACTA PAEDIATRICA, 2011, 100 (01) : 59 - 66
  • [4] Comparison of the Mortality and In-Hospital Outcomes of Preterm Infants Treated with Ibuprofen for Patent Ductus Arteriosus with or without Clinical Symptoms Attributable to the Patent Ductus Arteriosus at the Time of Ibuprofen Treatment
    Yoo, Hani
    Lee, Jin A.
    Oh, Sohee
    Jung, Young Hwa
    Sohn, Jin A.
    Shin, Seung Han
    Choi, Chang Won
    Kim, Ee-Kyung
    Kim, Han-Suk
    Kim, Beyong Il
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2017, 32 (01) : 115 - 123
  • [5] Effectiveness and Safety of Indomethacin versus Ibuprofen for the Treatment of Patent Ductus Arteriosus in Preterm Infants
    Sivanandan, Sindhu
    Bali, Varun
    Soraisham, Amuchou Singh
    Harabor, Andrei
    Kamaluddeen, Majeeda
    AMERICAN JOURNAL OF PERINATOLOGY, 2013, 30 (09) : 745 - 750
  • [6] Factors affecting the effectiveness of oral ibuprofen in the treatment of patent ductus arteriosus in preterm infants
    Ye, Chaohui
    Lyu, Qin
    Jiang, Linyan
    Yu, Li
    Xu, Yinquan
    Zhang, Jie
    Lu, Xiaodong
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (04) : 1074 - 1081
  • [7] Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants
    De Carolis, MP
    Romagnoli, C
    Polimeni, V
    Piersigilli, F
    Zecca, E
    Papacci, P
    Delogu, AB
    Tortorolo, G
    EUROPEAN JOURNAL OF PEDIATRICS, 2000, 159 (05) : 364 - 368
  • [8] Changes in urinary PGE2 after ibuprofen treatment in preterm infants with patent ductus arteriosus
    Antonucci, R.
    Cuzzolin, L.
    Arceri, A.
    Dessi, A.
    Fanos, V.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 65 (03) : 223 - 230
  • [9] Single-dose prophylactic ibuprofen therapy for patent ductus arteriosus in preterm infants
    Kim, Chae Young
    Chung, Sung-Hoon
    MEDICINE, 2022, 101 (31) : E29915
  • [10] Treatment of Patent Ductus Arteriosus: Indomethacin or Ibuprofen?
    Linder, Nehama
    Bello, Rachel
    Hernandez, Adriana
    Rosen, Chava
    Birk, Einat
    Sirota, Lea
    Pushkov, Yelena
    Klinger, Gil
    AMERICAN JOURNAL OF PERINATOLOGY, 2010, 27 (05) : 399 - 404